The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and survival outcomes of older patients with advanced pancreatic cancer (APC): A Canadian real-world evidence study.
 
Atul Batra
No Relationships to Disclose
 
Ravi Ramjeesingh
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; Lilly; Merck; Novartis Canada Pharmaceuticals Inc; Roche; Shire
Consulting or Advisory Role - Bayer; Celgene; SERVIER; Shire
Research Funding - Celgene (Inst); Eisai (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Novartis; Novartis Canada Pharmaceuticals Inc
 
Brandon M. Meyers
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; Merck; Purdue Pharma; Roche Canada; Shire; Taiho Pharmaceutical
Research Funding - AstraZeneca/MedImmune (Inst); Exelixis/Ipsen (Inst); Galera Therapeutics (Inst); GlaxoSmithKline Canada (Inst); H3 Biomedicine (Inst); Sillajen (Inst)
Expert Testimony - Eisai; Roche Canada
Travel, Accommodations, Expenses - Eisai; Merck Serono
 
Michael M. Vickers
No Relationships to Disclose
 
Rachel Anne Goodwin
Honoraria - Celgene; Eisai; Ipsen; Merck; Novartis; Pfizer; SERVIER
Consulting or Advisory Role - Celgene; Eisai; Ipsen; Merck; Novartis; Pfizer; SERVIER
Speakers' Bureau - Eisai; Ipsen
Research Funding - Ipsen
 
Dawn Elizabeth Armstrong
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose
 
Christina Kim
Research Funding - Celgene (Inst)